Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: the European Organisation for Research and Treatment of Cancer Chronotherapy Group.

Giacchetti, Sylvie; Bjarnason, Georg; Garufi, Carlo; Genet, Dominique; Iacobelli, Stefano; Tampellini, Marco; Smaaland, Rune; Focan, Christian; Coudert, Bruno; Humblet, Yves; Canon, Jean Luc; Adenis, Antoine; Lo Re, Giovanni; Carvalho, Carlos; Schueller, Johannes; Anciaux, Nicole; Lentz, Marie-Ange; Baron, Benoît; Gorlia, Thierry; Lévi, Francis

Giacchetti, Sylvie; Bjarnason, Georg; Garufi, Carlo; Genet, Dominique; Iacobelli, Stefano; Tampellini, Marco; Smaaland, Rune; Focan, Christian; Coudert, Bruno; Humblet, Yves; Canon, Jean Luc; Adenis, Antoine; Lo Re, Giovanni; Carvalho, Carlos; Schueller, Johannes; Anciaux, Nicole; Lentz, Marie-Ange; Baron, Benoît; Gorlia, Thierry; Lévi, Francis.

Affiliation

Giacchetti S; Hopital Paul Brousse and INSERM, Villejuif, France.

J Clin Oncol ; 24(22): 3562-9, 2006 Aug 01.

Article in En | MEDLINE | ID: mdl-16877722

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Chronotherapy Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: J Clin Oncol Year: 2006 Document type: Article Affiliation country: Country of publication:

Search on Google

Add to My VHL

XML

PubMed Links